Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-22-000014

Chief Medical Officer returned 199 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Podnos Yale · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-15 Returned to the company : show line 1 in the form −199 $2.03 $404 43,083 D
Loading xslF345X03/edgardoc.xml…